BML Capital Management, LLC
Holdings as of 2026-06-30, filed 2026-08-07
This is history, not a current position. These holdings describe 2026-06-30, and the report became public 38 days later. The portfolio has changed since.
Aggregates
computed from the positions belowPositions reported
18
Value reported by manager
$176.1M
Sum of our stored positions
$176.1M
should match the line above
Disclosure lag
38 d
quarter end to filing
Top 5 concentration
73.3%
of the positions shown
New positions
0
vs previous quarter
Exited
0
vs previous quarter
Option positions
3
puts and calls
Positions
18 largest shown| Issuer | Class | Value | Shares | Type | CUSIP |
|---|---|---|---|---|---|
| ACLARIS THERAPEUTICS INC | COM | $63.3M | 11,975,000 | — | 00461U105 |
| ATEA PHARMACEUTICALS INC | COM | $32.3M | 6,952,330 | — | 04683R106 |
| ENGENE THERAPEUTICS INC | COM *A* | $11.5M | 6,669,908 | — | 29286X101 |
| KRAFT HEINZ CO | COM | $11M | 465,000 | — | 500754106 |
| OUTSET MED INC | COM NEW | $10.9M | 2,519,701 | — | 690145206 |
| CARMAX INC | COM | $9.1M | 172,500 | — | 143130102 |
| TILLYS INC | CL A | $9M | 2,150,000 | — | 886885102 |
| PMV PHARMACEUTICALS INC | COM | $7.1M | 5,330,000 | — | 69353Y103 |
| INSTIL BIO INC | COM NEW | $5M | 645,600 | — | 45783C200 |
| TARGET CORP | COM | $4.9M | 37,500 | — | 87612E106 |
| ORAMED PHARMACEUTICALS INC | COM NEW | $4.2M | 866,269 | — | 68403P203 |
| JANUX THERAPEUTICS INC | COM | $2.4M | 154,961 | — | 47103J105 |
| PLIANT THERAPEUTICS INC | COM | $1.8M | 1,546,137 | — | 729139105 |
| CONNECT BIOPHARMA HLDGS LTD | SHS | $1.4M | 573,287 | — | G23549101 |
| IMAGENEBIO INC | COM | $1.2M | 200,730 | — | 45175G207 |
| WALMART INC | COM | $386.1K | 335 | Put | 931142103 |
| CORE SCIENTIFIC INC NEW | COM | $298K | 800 | Put | 21874A106 |
| TESLA INC | COM | $270K | 375 | Put | 88160R101 |
Values are shown exactly as filed. Before 2023 managers reported in thousands of dollars and afterwards in whole dollars; the reporting unit is not always determinable from the document, so nothing is converted automatically.
Source: U.S. Securities and Exchange Commission, Form 13F · as of 2026-08-07